| 持有 三生制药(01530)的基金 |
| 报告期：2024-12-31 |
| 序号 |
基金代码 |
基金简称 |
持仓市值(元) |
持仓数量(股) |
占基金净值比例(%) |
| 1 | 001878 | 嘉实沪港深精选股票 | 47,857,747.20 | 8,500,000.00 | 1.84 |
| 2 | 007291 | 汇丰晋信港股通双核混合 | 17,223,428.92 | 3,059,048.00 | 4.47 |
| 3 | 010286 | 海富通成长价值混合A | 12,276,919.74 | 2,180,500.00 | 0.88 |
| 4 | 010287 | 海富通成长价值混合C | 12,276,919.74 | 2,180,500.00 | 0.88 |
| 5 | 002666 | 前海开源沪港深创新成长混合A | 12,164,313.27 | 2,160,500.00 | 2.62 |
| 6 | 002667 | 前海开源沪港深创新成长混合C | 12,164,313.27 | 2,160,500.00 | 2.62 |
| 7 | 009139 | 嘉实瑞成两年持有期混合C | 11,260,646.40 | 2,000,000.00 | 1.20 |
| 8 | 009138 | 嘉实瑞成两年持有期混合A | 11,260,646.40 | 2,000,000.00 | 1.20 |
| 9 | 010436 | 富国双债增强债券C | 10,854,640.00 | 1,928,000.00 | 0.56 |
| 10 | 010435 | 富国双债增强债券A | 10,854,640.00 | 1,928,000.00 | 0.56 |
| 11 | 002332 | 汇丰晋信沪港深股票A | 8,625,655.14 | 1,532,000.00 | 3.80 |
| 12 | 002333 | 汇丰晋信沪港深股票C | 8,625,655.14 | 1,532,000.00 | 3.80 |
| 13 | 006228 | 中欧医疗创新股票A | 5,945,621.30 | 1,056,000.00 | 0.08 |
| 14 | 006229 | 中欧医疗创新股票C | 5,945,621.30 | 1,056,000.00 | 0.08 |
| 15 | 005269 | 华泰柏瑞港股通量化混合 | 1,559,599.53 | 277,000.00 | 1.38 |
| 16 | 519139 | 海富通沪港深混合 | 1,441,362.74 | 256,000.00 | 2.38 |
| 17 | 007357 | 创金合信港股通量化股票C | 1,294,974.34 | 230,000.00 | 0.40 |
| 18 | 007354 | 创金合信港股通量化股票A | 1,294,974.34 | 230,000.00 | 0.40 |
| 19 | 006781 | 汇丰晋信港股通精选股票 | 861,439.45 | 153,000.00 | 1.60 |
| 20 | 005707 | 富国港股通量化精选股票 | 624,965.88 | 111,000.00 | 1.19 |
| 21 | 001942 | 前海开源沪港深汇鑫混合A | 484,207.80 | 86,000.00 | 0.91 |
| 22 | 001943 | 前海开源沪港深汇鑫混合C | 484,207.80 | 86,000.00 | 0.91 |
| 23 | 004532 | 民生加银中证港股通指数A | 258,994.87 | 46,000.00 | 0.35 |
| 24 | 004533 | 民生加银中证港股通指数C | 258,994.87 | 46,000.00 | 0.35 |
| 25 | 009155 | 海富通富盈混合C | 143,573.24 | 25,500.00 | 0.15 |
| 26 | 009154 | 海富通富盈混合A | 143,573.24 | 25,500.00 | 0.15 |
| 27 | 501303 | 广发恒生中型股指数(LOF)A | 137,942.92 | 24,500.00 | 0.42 |
| 28 | 004996 | 广发恒生中型股指数(LOF)C | 137,942.92 | 24,500.00 | 0.42 |
| 29 | 009156 | 海富通富泽混合A | 78,824.52 | 14,000.00 | 0.11 |
| 30 | 009157 | 海富通富泽混合C | 78,824.52 | 14,000.00 | 0.11 |
